Elephants Help U.S. and Israeli Researchers Make Giant Stride Toward Cancer Cure

Scientists from Israel's Technion hope to translate the elephants’ defense mechanisms into a cancer drug, after a new American study reveals why the large mammals rarely get the disease.

comments Print
A new American study has revealed that the reason elephants rarely get cancer is a special mechanism in their cells that battles the disease.